Know Cancer

or
forgot password

Prevalence, Incidence and Predictors of Central Airway Obstruction in Patients With Advanced Lung Cancer


N/A
18 Years
85 Years
Open (Enrolling)
Both
Lung Cancer

Thank you

Trial Information

Prevalence, Incidence and Predictors of Central Airway Obstruction in Patients With Advanced Lung Cancer


Inclusion Criteria:



- Advanced lung cancer with indication for chemotherapy or chemotherapy + radiation
therapy

Exclusion Criteria:

- Age < 18 year

- Pregnancy

- Refusal to sign informed consent

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Incidence of central airway obstruction

Outcome Description:

The incidence will be measured over a 12 month period after diagnosis (or over the life span from diagnosis to death in patients who die before 1 year from the diagnosis)

Outcome Time Frame:

12 months

Safety Issue:

No

Principal Investigator

Rocco Trisolini, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Maggiore Bellaria Hospital, Bologna, Italy

Authority:

Italy: Ethics Committee

Study ID:

13002-Trisolini

NCT ID:

NCT01799395

Start Date:

February 2013

Completion Date:

March 2015

Related Keywords:

  • Lung Cancer
  • Airway Obstruction
  • Lung Neoplasms

Name

Location